FETEM: in MS (type not specified), phase 4

AMANTADINE AND TRANSCRANIAL MAGNETIC STIMULATION FOR TREATING FATIGUE IN MULTIPLE SCLEROSIS: PHASE III STUDY, CONTROLLED, RANDOMIZED, CROSSED OVER AND DOUBLE BLIND

OngoingPhase 4MS (type not specified)2021-004868-95

What was tested

Compared with

Amantadine

What it measured

Main measures

Compare clinical response to amantadine, TMS or the combination
Nerve conduction tests

Other measures (1)

1. Cognitive recovery measured by SDMT test
Thinking and memory

Papers

Results
Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial.
BMJ Open · 2024

Loading reviews and guidelines…

History

Oct 2026In scope changed from true to false

Started
Dec 2021

Assembled by software from public sources.